Harmony Biosciences Holdings, Inc. (HRMY): Capital Expenditures
$310.0K
Year ended 2025-12-31
+21.7%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $310.0K | -73.1% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $1.15M | +269.6% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $312.0K | +81.4% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $172.0K | -42.3% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $298.0K | n/m | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $2.0K | -98.7% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $149.0K | n/a | 2022-02-28, From 2019-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $310.0K | -73.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $13.84M | -14.8% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.67M | -84.0% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $51.44M | +13.6% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.74M | +5.3% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $211.0K | -90.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $13.80M | -39.7% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $15.33M | +44.2% |
Compare HRMY, ANIP, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗